Archives — Current Month (7)
Phase 2 Study Begins for German Biopharma's Cancer Drug Candidate (01/16/2019)
A LifeSci Capital report discussed two current trials in which this therapeutic is being evaluated.
Biotech's Flu Vaccine Shows 'Superiority to Market Leader' in Data (01/11/2019)
Study findings that differentiate this product from competitors were reviewed in a Ladenburg Thalmann research report.
Healthcare Solutions Provider to Acquire Medical Software Firm (01/10/2019)
The merger will allow the Canadian company to expand its online technology platform.
Target Raised on Nutraceutical Firm After It Inks 'Marquee Partnership' (01/09/2019)
The agreement terms and benefits of the partnership to this pharmaceutical company were relayed in an H.C. Wainwright & Co. report.
Biotech Enters License Agreement to Validate Biomarker as Alternative NASH Diagnostic (01/05/2019)
The background and justification for the deal was covered in an H.C. Wainwright & Co. report.
Potential Tenbagger Biopharma Displays 'Strong Start to New Year' (01/04/2019)
A ROTH Capital Partners report discussed the recent trial launch and provided upcoming catalysts for the stock.
Texas-Based Biopharma Gets PDUFA Date for Lead Orphan Disease Asset (01/02/2019)
An H.C. Wainwright & Co. report covered the potential timeline to market and subsequent estimated revenue for this therapeutic, which addresses a rare disorder in collagen production.
More Archives
2019
2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
